CN102631435A - Medicament for treating rheumatoid arthritis - Google Patents

Medicament for treating rheumatoid arthritis Download PDF

Info

Publication number
CN102631435A
CN102631435A CN2012101308947A CN201210130894A CN102631435A CN 102631435 A CN102631435 A CN 102631435A CN 2012101308947 A CN2012101308947 A CN 2012101308947A CN 201210130894 A CN201210130894 A CN 201210130894A CN 102631435 A CN102631435 A CN 102631435A
Authority
CN
China
Prior art keywords
medicament
rheumatoid arthritis
treating rheumatoid
medicine
treatment
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN2012101308947A
Other languages
Chinese (zh)
Inventor
马守云
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to CN2012101308947A priority Critical patent/CN102631435A/en
Publication of CN102631435A publication Critical patent/CN102631435A/en
Pending legal-status Critical Current

Links

Landscapes

  • Medicines Containing Plant Substances (AREA)

Abstract

The invention relates to the field of Chinese herbal medicaments and in particular relates to a medicament for treating rheumatoid arthritis by using Chinese medicaments as bulk pharmaceutical chemicals. The medicament consists of raw bighead atractylodes rhizome, poria, notopterygium root, radix angelicae pubescentis, asarum, ephedra, white peony root, white mustard seed, eucommia bark, pawpaw, peach kernel, safflower, long-noded pit viper and pangolin. The preparation method comprises the following steps: uniformly mixing the bulk pharmaceutical chemicals at a weight ratio; crushing the mixture into powder of 100-120 meshes; sterilizing and disinfecting according to a conventional method; and preparing water-bindered pills by use of a binder. The medicament has the efficacies of dispelling wind and removing obstruction in the meridians, activating blood, warming channel and expelling cold and nourishing bones and tonifying yang, has a remarkable curative effect in treating rheumatoid arthritis. The medicament with the efficacies of dispelling wind and removing obstruction in the meridians, activating blood, warming channel and expelling cold and nourishing bones and tonifying yang has a remarkable curative effect in treating rheumatoid arthritis.

Description

A kind of medicine of treating rheumatoid arthritis
Technical field
The present invention relates to field of Chinese herbal, especially relating to a kind of is the medicine of the treatment rheumatoid arthritis of crude drug preparation with Chinese medicine.
Background technology
Rheumatic arthritis is a kind of common acute or chronic ICT.Can show effect repeatedly and involve heart.Clinical miserable with joint and muscle the. fugitive, heavily work, pain is characteristic.Belong to allergic disease.Be one of main performance of rheumatic fever, how with febris acuta and arthralgia onset.Onset is early stage how similar with anemofrigid cold, is difficult for being paid attention to by people, mainly shows as waist and lower limb and sends out cold, aversion to wind, pain; The chance cold rnning is acute, and activity is stretched pain in the wrong not freely; Like untimely treatment; How to the later stage joint deformity, pain unbearably and cause the disease of heart kidney is in the misery patient for a long time.
Anti-inflammation analgesic, hormone medicine are used in the treatment of rheumatic arthritis more, but can not be effected a radical cure, and take said medicine for a long time, side effect is big at present.
Summary of the invention
The purpose of this invention is to provide a kind of is the medicine of the treatment rheumatic arthritis of crude drug preparation with Chinese medicine, this medicine with dispelling wind and removing obstruction in the collateral, invigorate blood circulation, dispelling cold by warming the meridian, the tonifying YANG of benefit bone be the principle treatment, therapeutic effect is good, expense is low.
Medicine of the present invention is that crude drug prepares by following parts by weight of traditional Chinese medicines:
Rhizoma Atractylodis Macrocephalae 12-16 Poria 12-15
Rhizoma Et Radix Notopterygii 9-12 Radix Angelicae Pubescentis 15-20
Herba Asari 6-9 Herba Ephedrae 6-10
Radix Paeoniae Alba 15-20 Semen Sinapis Albae 12-15
Cortex Eucommiae 12-15 Fructus Chaenomelis 10-15
Semen Persicae 9-12 Flos Carthami 9-12
Agkistrodon 30-50 Squama Manis 8-12.
The medicine of above-mentioned each component can be processed said peroral dosage form on any pharmaceuticss such as tablet, pill, powder, capsule, and the preferred dosage form of the present invention is a water pill.
The concrete method for preparing of medicine water pill of the present invention agent is: said medicine by said parts by weight mix homogeneously, is ground into 100~120 purpose medicated powder, and sterilization uses binding agent to make the water pill product by conventional method.
In the prescription of the present invention, Rhizoma Atractylodis Macrocephalae invigorating the spleen and benefiting QI, dampness diuretic; Poria has eliminating dampness and diuresis, invigorating the spleen and regulating the stomach, the effect of mind tranquilizing and the heart calming; The Rhizoma Et Radix Notopterygii exterior cold of loosing, wind-damp dispelling, sharp joint, pain relieving; The Radix Angelicae Pubescentis expelling wind and dampness, dispersing cold for relieving pain; The Herba Asari cold expelling that induces sweat, wind-expelling pain-stopping, warming the lung to resolve fluid-retention, sensible; Herba Ephedrae diaphoresis cold expelling, depressed lung-energy dispersing, inducing diuresis to remove edema; Radix Paeoniae Alba nourishing blood to suppress the hyperactive liver, slow middle pain relieving, yin fluid astringing is received antiperspirant; Semen Sinapis Albae warming the lung eliminating phlegm promoting the circulation of QI, the resolving mass and removing the obstruction of the collateral pain relieving; Cortex Eucommiae blood pressure lowering, invigorating the liver and kidney, bone and muscle strengthening; Can also relieve summer heat after Fructus Chaenomelis is aid digestion quench one's thirst, nourishing the lung to arrest cough; The Semen Persicae blood circulation promoting and blood stasis dispelling, loosening bowel to relieve constipation, relieving cough and asthma; The Flos Carthami latus rectum of invigorating blood circulation, eliminating stasis to stop pain; Agkistrodon is dispeled the wind, collateral dredging; Squama Manis is used for blood circulation promoting and dispersing pathogen accumulation, the stimulating milk secretion of stimulating the menstrual flow, and eliminating carbuncle is burst hard.All medicines share, and can play dispelling wind and removing obstruction in the collateral, invigorate blood circulation, the effect of dispelling cold by warming the meridian, the tonifying YANG of benefit bone, and are evident in efficacy to treatment rheumatic arthritis.
For further investigating the clinical efficacy of Drug therapy rheumatic arthritis of the present invention, select 63 routine rheumatic arthritis patients to carry out clinical observation on the therapeutic effect.
Be divided into treatment group and matched group to 63 routine patients, 30 people are organized in treatment, matched group 33 people.
All case is all according to the diagnosis basis in " new Chinese medicine clinical research guideline (first volume) ":
1. clinical manifestation: the streptococcal infection medical history is arranged more; Acute stage, can have multiple and the the. fugitive joint aches, mostly occurs in big joint, can be with redness pain or tuberosity or erythema; Chronic phase, can only be felt joint aches.
2. laboratory examination: anti-" O " is more than 1:500; Or erythrocyte sedimentation rate speeds; Or antistreptokinase surpasses more than 80 units; Or antihyaluronidase is more than 128 units; Or C reflection protein positive.
3. X-ray film does not have the sclerotin damage.
Be diagnosed as rheumatic arthritis.
Therapeutic Method
Matched group adopt to use Western medicine ibuprofen commonly used, and adopted name is an ibuprofen modified release capsule, production firm: Sino-America Tianjin Shike Pharmaceutical Co., Ltd., every day 1 time, one time 2;
The treatment group adopts water pill drug form of the present invention, every day 2 times, each 10 grams.
After the treatment, to treatment group and the inspection of the matched group patient chamber of experimentizing, the result is following:
The variation of each parameter before and after the rheumatic arthritis patient treatment
Figure 192013DEST_PATH_IMAGE002
Criterion of therapeutical effect
Criterion of therapeutical effect with reference to " new Chinese medicine clinical research guideline (first volume) ".Cure: the arthralgia of getting involved after the treatment disappears, and function of joint is improved or recovered normal, and it is normal that erythrocyte sedimentation rate, rheumatoid factor have been recovered; Produce effects: the arthralgia of getting involved is clearly better or disappears, and erythrocyte sedimentation rate, rheumatoid factor titre reduce, or has recovered normal, but arthroncus does not disappear as yet; Effectively: the arthralgia of getting involved after the treatment or swell and ache and take a favorable turn; Invalid: with compare each side and do not have progress before the treatment.
Two groups of case treatment back curative effect comparative results are seen table 1.
Table 1 liang group case treatment back curative effect relatively
Group The example number Cure n (%) Effective n (%) Invalid n (%) Total effective rate n (%)
Matched group 33 11(33.3) 14(42.5) ?8(24.2) 25(75.8)
The treatment group 30 17(56.7) 9(30) 4(13.3) 26(86.7)
Clinical test results proves that drug effect of the present invention obviously is superior to matched group, does not see any untoward reaction.
The specific embodiment
Embodiment 1
Get Rhizoma Atractylodis Macrocephalae 16kg, Poria 15 kg, Rhizoma Et Radix Notopterygii 12 kg, Radix Angelicae Pubescentis 20 kg, Herba Asari 9 kg; Herba Ephedrae 10 kg, the Radix Paeoniae Alba 20 kg, Semen Sinapis Albae 15 kg, the Cortex Eucommiae 15 kg; Fructus Chaenomelis 15 kg, Semen Persicae 12 kg, Flos Carthami 12 kg, Agkistrodon 50 kg; Squama Manis 12 kg by said weight mix homogeneously, are ground into 100~120 purpose medicated powder with said medicine, and sterilization uses binding agent to make the water pill product by conventional method.
Embodiment 2
Get Rhizoma Atractylodis Macrocephalae 12kg, Poria 12kg, Rhizoma Et Radix Notopterygii 9kg, Radix Angelicae Pubescentis 15kg, Herba Asari 6kg; Herba Ephedrae 6kg, Radix Paeoniae Alba 15kg, Semen Sinapis Albae 12 kg, Cortex Eucommiae 12kg; Fructus Chaenomelis 10 kg, Semen Persicae 9kg, Flos Carthami 9kg, Agkistrodon 30kg; Squama Manis 8kg by said weight mix homogeneously, is ground into 100~120 purpose medicated powder with said medicine, and sterilization uses binding agent to make the water pill product by conventional method.

Claims (2)

1. medicine of treating rheumatoid arthritis is that crude drug prepares by following parts by weight of traditional Chinese medicines:
Rhizoma Atractylodis Macrocephalae 12-16 Poria 12-15
Rhizoma Et Radix Notopterygii 9-12 Radix Angelicae Pubescentis 15-20
Herba Asari 6-9 Herba Ephedrae 6-10
Radix Paeoniae Alba 15-20 Semen Sinapis Albae 12-15
Cortex Eucommiae 12-15 Fructus Chaenomelis 10-15
Semen Persicae 9-12 Flos Carthami 9-12
Agkistrodon 30-50 Squama Manis 8-12.
2. the medicine of treatment rheumatoid arthritis according to claim 1 is characterized in that described medicine is processed water pill.
CN2012101308947A 2012-05-01 2012-05-01 Medicament for treating rheumatoid arthritis Pending CN102631435A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN2012101308947A CN102631435A (en) 2012-05-01 2012-05-01 Medicament for treating rheumatoid arthritis

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN2012101308947A CN102631435A (en) 2012-05-01 2012-05-01 Medicament for treating rheumatoid arthritis

Publications (1)

Publication Number Publication Date
CN102631435A true CN102631435A (en) 2012-08-15

Family

ID=46616114

Family Applications (1)

Application Number Title Priority Date Filing Date
CN2012101308947A Pending CN102631435A (en) 2012-05-01 2012-05-01 Medicament for treating rheumatoid arthritis

Country Status (1)

Country Link
CN (1) CN102631435A (en)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN105695263A (en) * 2016-03-23 2016-06-22 黄群德 Traditional Chinese medicinal health-care wine
CN105920133A (en) * 2016-04-29 2016-09-07 苏州市天灵中药饮片有限公司 Medicinal liquor capable of alleviating rheumatism and preparation method thereof

Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1279966A (en) * 2000-07-07 2001-01-17 王洪 Chinese medicine composition for curing spur and hyperosteoeny and its preparing method
CN1350852A (en) * 2000-10-30 2002-05-29 兰州三极生物资源技术公司 Medicine for treating rheumatic or rheumatoid arthritis, osteoarthropathy and gout
CN1846770A (en) * 2006-02-20 2006-10-18 毕敬东 Ointment for treating rheumatism, wound pain and swelling boil
CN1857541A (en) * 2006-03-15 2006-11-08 刘少华 Plaster for treating rheumatism and osteoarthrosis
CN101181384A (en) * 2007-11-27 2008-05-21 黄毅 Chinese medicine decoction for curing rheumatic arteritis and atrophic arthritis
WO2011126295A2 (en) * 2010-04-06 2011-10-13 (주)아모레퍼시픽 Wrapping fermentation method using medicinal leaves, and composition for external skin application using same

Patent Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1279966A (en) * 2000-07-07 2001-01-17 王洪 Chinese medicine composition for curing spur and hyperosteoeny and its preparing method
CN1350852A (en) * 2000-10-30 2002-05-29 兰州三极生物资源技术公司 Medicine for treating rheumatic or rheumatoid arthritis, osteoarthropathy and gout
CN1846770A (en) * 2006-02-20 2006-10-18 毕敬东 Ointment for treating rheumatism, wound pain and swelling boil
CN1857541A (en) * 2006-03-15 2006-11-08 刘少华 Plaster for treating rheumatism and osteoarthrosis
CN101181384A (en) * 2007-11-27 2008-05-21 黄毅 Chinese medicine decoction for curing rheumatic arteritis and atrophic arthritis
WO2011126295A2 (en) * 2010-04-06 2011-10-13 (주)아모레퍼시픽 Wrapping fermentation method using medicinal leaves, and composition for external skin application using same

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN105695263A (en) * 2016-03-23 2016-06-22 黄群德 Traditional Chinese medicinal health-care wine
CN105920133A (en) * 2016-04-29 2016-09-07 苏州市天灵中药饮片有限公司 Medicinal liquor capable of alleviating rheumatism and preparation method thereof

Similar Documents

Publication Publication Date Title
CN102309644A (en) Traditional Chinese medical composition for treating bone fracture
CN104523865B (en) Medicine for treating breast diseases
CN101919988B (en) Medicine compound for curing rheumatism rheumatoid arthritis and preparation method thereof
CN101524450B (en) Oral traditional Chinese medicine for setting bones and relieving rigidity of muscles and preparation method thereof
CN102166277A (en) Waist healing pill
CN103566236B (en) A kind for the treatment of of arthritis and promoting collateral and channels Chinese medicine preparation
CN101703662B (en) Oral Chinese medicament for treating hyperosteogeny
CN103211886A (en) Medicament for treating rheumatic arthritis
CN102526482A (en) Traditional Chinese medicine preparation for treating lumbar disc herniation
CN102631435A (en) Medicament for treating rheumatoid arthritis
CN104587206A (en) Medicament for treating bedsore and preparation method of medicament
CN101653490A (en) Medicine for treating simple appendicitis
CN101708292B (en) Chinese medicament for treating rheumatic and rheumatoid diseases
CN103417788B (en) One treats fracture Chinese medicine for oral administration
CN102038930A (en) Medicament for treating protrusion of lumbar vertebral disc
CN103784824A (en) Chinese herbal preparation for treating lumbar disc herniation and rheumatoid
CN102406870A (en) Medicament for treating rheumatic arthralgia
CN102008635A (en) Traditional Chinese medicine preparation for treating acute pancreatitis
CN102430096B (en) Medicament for treating rheumatic or rheumatoid diseases
CN102205096A (en) Medicament for treating adnexitis and pelvic inflammation
CN102145099A (en) Traditional Chinese medicine for treating infertility caused by liver stagnation
CN104069342A (en) Traditional Chinese medicine for treating acute heart failure
CN103157011B (en) Traditional Chinese medicine composite for promoting fracture healing
CN102764325B (en) Chinese medicinal composition for dispelling rheumatism and relieving pain
CN102961662B (en) Medicine for treating gastric ulcer and preparation method thereof

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
WD01 Invention patent application deemed withdrawn after publication

Application publication date: 20120815

WD01 Invention patent application deemed withdrawn after publication